RAFFX
Price
$44.82
Change
-$0.96 (-2.10%)
Updated
Feb 21 closing price
Net Assets
89.95B
RGAGX
Price
$76.88
Change
-$1.85 (-2.35%)
Updated
Feb 21 closing price
Net Assets
304.33B
Ad is loading...

RAFFX vs RGAGX

Header iconRAFFX vs RGAGX Comparison
Open Charts RAFFX vs RGAGXBanner chart's image
American Funds AMCAP R5
Price$44.82
Change-$0.96 (-2.10%)
VolumeN/A
Net Assets89.95B
American Funds Growth Fund of Amer R6
Price$76.88
Change-$1.85 (-2.35%)
VolumeN/A
Net Assets304.33B
RAFFX vs RGAGX Comparison Chart
Loading...
View a ticker or compare two or three
VS
RAFFX vs. RGAGX commentary
Feb 23, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is RAFFX is a Buy and RGAGX is a Hold.

Ad is loading...
FUNDAMENTALS
Fundamentals
RGAGX has more cash in the bank: 304B vs. RAFFX (90B). RAFFX pays higher dividends than RGAGX: RAFFX (0.89) vs RGAGX (0.75). RAFFX was incepted earlier than RGAGX: RAFFX (23 years) vs RGAGX (16 years). RAFFX (31.00) and RGAGX (31.00) have comparable annual turnover. RAFFX (250) and RGAGX (250) have matching initial minimum investment requirements. RGAGX annual gain was more profitable for investors over the last year : 12.78 vs. RAFFX (7.37). RGAGX return over 5 years is better than : 44.25 vs. RAFFX (29.01).
RAFFXRGAGXRAFFX / RGAGX
Total Expense RatioN/AN/A-
Annual Report Gross Expense RatioN/AN/A-
Fund Existence23 years16 years-
Gain YTD2.1193.12568%
Front LoadN/AN/A-
Min. Initial Investment250250100%
Min. Initial Investment IRAN/AN/A-
Net Assets90B304B30%
Annual Yield % from dividends0.890.75119%
Returns for 1 year7.3712.7858%
Returns for 3 years15.7324.0465%
Returns for 5 years29.0144.2566%
Returns for 10 years56.0475.5574%
View a ticker or compare two or three
Ad is loading...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
EXC43.390.22
+0.51%
Exelon Corp
GTES22.25-1.06
-4.55%
Gates Industrial Corp
CRGY14.26-0.75
-5.00%
Crescent Energy Company
AMLX3.30-0.22
-6.25%
Amylyx Pharmaceuticals
ELEV0.61-0.04
-6.53%
Elevation Oncology